Certainly! Here is the content formatted with the appropriate heading designations: The synthetic biology sector is on a trajectory to monumental expansion, expected to reach a valuation of $52.6 billion by 2030. This interdisciplinary field combines biology, engineering, computer science, and
Swedish newcomer Ironic Biotech has just placed itself at the forefront of the dietary supplement market by securing a hefty €1 million in pre-seed funding. Their breakthrough in developing heme iron from plant sources could drastically alter how we combat iron deficiencies worldwide. As the global
At the recent BPI Europe 2024 conference, a landmark discussion led by Uwe Buecheler from Boehringer Ingelheim marked the dawn of a new chapter in biopharmaceuticals. Described as the 'third wave' of biologics, it signifies an era brimming with groundbreaking therapeutic innovations that stand to
